Genentech (Weighted Average Cost of Capital (WACC) Analysis)
 Improve your investment analysis with by seeing the Genentech's Discounted Cash Flow analysis, Genentech's Warren Buffet analysis, and Genentech's Comparable Multiple analysis.  Helpful Information for Genentech's AnalysisWhat is the WACC Formula? Analyst use the WACC Discount Rate (weighted average cost of capital) to determine Genentech's investment risk. WACC Formula = Cost of Equity (CAPM) * Common Equity + (Cost of Debt) * Total Debt. The result of this calculation is an essential input for the discounted cash flow (DCF) analysis for Genentech. Value Investing Importance? This method is widely used by investment professionals to determine the correct price for investments in Genentech before they make value investing decisions. This WACC analysis is used in Genentech's discounted cash flow (DCF) valuation and see how the WACC calculation affect's Genentech's company valuation. |
WACC Analysis Information1. The WACC (discount rate) calculation for Genentech uses comparable companies to produce a single WACC (discount rate). An industry average WACC (discount rate) is the most accurate for Genentech over the long term. If there are any short-term differences between the industry WACC and Genentech's WACC (discount rate), then Genentech is more likely to revert to the industry WACC (discount rate) over the long term. 2. The WACC calculation uses the higher of Genentech's WACC or the risk free rate, because no investment can have a cost of capital that is better than risk free. This situation may occur if the beta is negative and Genentech uses a significant proportion of equity capital. |